Uzma H. Siddiqui, MD

Director, Neuroscience Clinical Leader, Established Products
Johnson & Johnson

Poster(s):

• (212) An Active Safety Surveillance Using Real-World Evidence (ASSURE) Approach to Pharmacovigilance Signal Evaluation: The case of methylphenidate and potential signal for obsessive-compulsive disorders
  Tuesday, August 27, 2024

  8:00 AM – 6:00 PM CEST